Searched for
NVX
Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsLast month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...- NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portalThe DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9,...
- SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsThe Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- Govt panel likely to decide on Covovax as a heterologous booster dose for adults on WednesdayPrakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the D...
- Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dosePrakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for the heterologous bo...
- SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Novavax files for emergency use listing of COVID-19 vaccine with WHOEarlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisa...
- Serum Institute manufacturing first batch of Covovax COVID-19 vaccine, says Adar PoonawallaIn March this year, Poonawalla had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it ...
- Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
- Covovax trials begin in India, hope to launch it by Sept 2021: Adar PoonawallaIn August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation ...
- GAVI inks pact with Serum Institute of India, Novavax for Covid-19 vaccine supplyThe Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...
- Serum Institute of India plans to launch Covovax by June: Adar PoonawallaSII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We...
- Booster shot for India: Novavax vaccine shows 90% efficacy, J&J 66%Novavax said its NVX-CoV2373 demonstrated a 90% efficacy in phase 3 trials in the UK, taking it closer to approval by the UK health authori...
- AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin"AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. This is a whole-virion inactivated vaccine co-sponsored by Indian Council...
- Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists sayThe decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...
- Novavax on track to begin U.S. trial of COVID-19 vaccine this monthThe company also said the vaccine, NVX-CoV2373, had gained the U.S. Food and Drug Administration's "fast-track" status and that expected da...
- Novavax aims for 2 bn COVID-19 vaccine doses with expanded India dealU.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...
- Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccineThe Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from t...
- Covid-19: The frantic search for a cure continuesThough vaccine makers are jumping the usual loops of trial development, regulatory agencies are stepping in to ensure that the companies ar...
Load More
